Applied DNA Sciences, Inc.
APDN
$3.00
-$0.26-7.98%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -35.62% | 5.79% | 34.27% | 4.28% | -83.79% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -35.62% | 5.79% | 34.27% | 4.28% | -83.79% |
| Cost of Revenue | 30.02% | -- | -22.36% | -18.91% | -86.03% |
| Gross Profit | -97.90% | -- | 196.02% | 210.00% | -80.89% |
| SG&A Expenses | 11.18% | -- | -14.63% | -18.92% | -19.94% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.81% | -2.25% | -11.10% | -17.50% | -34.58% |
| Operating Income | -11.73% | 4.31% | 21.78% | 21.57% | -15.64% |
| Income Before Tax | -293.70% | -- | -136.11% | 8.35% | 160.47% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -293.70% | -- | -136.11% | 8.35% | 160.47% |
| Earnings from Discontinued Operations | -894.67% | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 27.72% | -- | 16.27% | -27.35% | 110.42% |
| Net Income | -309.88% | 26.09% | -138.84% | 8.23% | 160.64% |
| EBIT | -11.73% | 4.31% | 21.78% | 21.57% | -15.64% |
| EBITDA | -13.98% | 2.57% | 16.75% | 16.84% | -26.38% |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |